Chengwei Luo

Guangzhou, 510080, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

MRD-driven HDACi-based therapy post-transplant: a real-world study in high-risk acute myeloid leukemia.

MRD-driven HDACi-based therapy post-transplant: a real-world study in high-risk acute myeloid leukemia.

Journal: Annals of hematology

Published: November 20, 2025

Dual-track drive for precision education: developing a targeted teaching model in the standardized training of lymphoma subspecialty physicians through the integration of problem-based learning and case-based learning.

Dual-track drive for precision education: developing a targeted teaching model in the standardized training of lymphoma subspecialty physicians through the integration of problem-based learning and case-based learning.

Journal: BMC medical education

Published: July 17, 2025

Targeting UGCG sensitizes AML cells to venetoclax through RAB32-mediated endoplasmic reticulum-mitochondria communication.

Targeting UGCG sensitizes AML cells to venetoclax through RAB32-mediated endoplasmic reticulum-mitochondria communication.

Journal: Cell reports

Published: September 24, 2024

Efficacy and safety of sovleplenib (HMPL-523) in adult patients with chronic primary immune thrombocytopenia in China (ESLIM-01): a randomised, double-blind, placebo-controlled, phase 3 study.

Efficacy and safety of sovleplenib (HMPL-523) in adult patients with chronic primary immune thrombocytopenia in China (ESLIM-01): a randomised, double-blind, placebo-controlled, phase 3 study.

Journal: The Lancet. Haematology

Published: April 02, 2024

Sovleplenib (HMPL-523), a novel Syk inhibitor, for patients with primary immune thrombocytopenia in China: a randomised, double-blind, placebo-controlled, phase 1b/2 study.

Sovleplenib (HMPL-523), a novel Syk inhibitor, for patients with primary immune thrombocytopenia in China: a randomised, double-blind, placebo-controlled, phase 1b/2 study.

Journal: The Lancet. Haematology

Published: November 07, 2022

Loss of miR-31-5p drives hematopoietic stem cell malignant transformation and restoration eliminates leukemia stem cells in mice.

Loss of miR-31-5p drives hematopoietic stem cell malignant transformation and restoration eliminates leukemia stem cells in mice.

Journal: Science translational medicine

Published: January 26, 2022

von Willebrand Factor as a Predictor for Transplant-Associated Thrombotic Microangiopathy.

von Willebrand Factor as a Predictor for Transplant-Associated Thrombotic Microangiopathy.

Journal: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

Published: February 25, 2020

circMYBL2, a circRNA from MYBL2, regulates FLT3 translation by recruiting PTBP1 to promote FLT3-ITD AML progression.

circMYBL2, a circRNA from MYBL2, regulates FLT3 translation by recruiting PTBP1 to promote FLT3-ITD AML progression.

Journal: Blood

Published: March 26, 2019

ORP4L Extracts and Presents PIP2 from Plasma Membrane for PLCβ3 Catalysis: Targeting It Eradicates Leukemia Stem Cells.

ORP4L Extracts and Presents PIP2 from Plasma Membrane for PLCβ3 Catalysis: Targeting It Eradicates Leukemia Stem Cells.

Journal: Cell reports

Published: October 16, 2018

A potent immunomodulatory role of exosomes derived from mesenchymal stromal cells in preventing cGVHD.

A potent immunomodulatory role of exosomes derived from mesenchymal stromal cells in preventing cGVHD.

Journal: Journal of hematology & oncology

Published: October 10, 2018

Emerging role of C5a/C5aR IL-17A axis in cGVHD.

Emerging role of C5a/C5aR IL-17A axis in cGVHD.

Journal: American journal of translational research

Published: April 02, 2018

The Synergistic Effects of Decitabine Combined with Arsenic Trioxide (ATO) in the Human Myelodysplastic Syndrome Cell Line SKM-1.

The Synergistic Effects of Decitabine Combined with Arsenic Trioxide (ATO) in the Human Myelodysplastic Syndrome Cell Line SKM-1.

Journal: Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion

Published: April 23, 2015

Showing 1-12 of 13

Last Updated: 09/26/2026